Emicizumab bij kinderen met hemofilie A met inhibitoren

Delen via:
ASH Annual Meeting 2017

Log hier in om volledige toegang te krijgen.

Login of Account maken

 

Bronnen:
Young G, Sidonio RF, Liesner R, et al. HAVEN 2 Updated Analysis: Multicenter, Open-Label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Pediatric Patients with Hemophilia A with Inhibitors. ASH 59th Annual Meeting & Exhibition, abstract 85.